Shilan Seyed Ahmadi
4PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Nov 12, 2025
Design and methods of the Ixekizumab Diabetes Intervention Trial (I-DIT): protocol for a phase 2, randomised, multicentre, placebo-controlled, double-blind trial of anti-interleukin 17 as a treatment option for adults with new-onset type 1 diabetes.Shilan Seyed Ahmadi, Olle Korsgren, Per-Anders Jansson
|Feb 24, 2022
Risk factors for nephropathy in persons with type 1 diabetes: a population-based study.Shilan Seyed Ahmadi, Aldina Pivodic, Ann-Marie Svensson
|Jul 10, 2020
The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4).Shilan Seyed Ahmadi, Klara Westman, Aldina Pivodic
|Jan 20, 2020
Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study.Shilan Seyed Ahmadi, Ann-Marie Svensson, Aldina Pivodic
Pageof 1
